Drug class
Melatonergic antidepressant
Mechanism of action
Acts as an agonist at melatonin MT1 and MT2 receptors and an antagonist at 5-HT2C receptors; it can resynchronise circadian rhythms.
General use cases
- Treatment of major depressive episodes in adults
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
